What the Walgreens TV commercial - Shot at Life is about.
The Walgreens TV Spot, 'Shot at Life' is a powerful advertisement that highlights the importance of getting vaccinated. The commercial starts with a narration from a teenager who explains how she was able to receive a vaccine that prevented a serious illness. She thanks her parents for making sure she got her shots and urges others to do the same.
The scene then shifts to a series of individuals from different backgrounds, professions, and ages who all share their stories of receiving vaccinations. One man talks about how his vaccine saved him from a deadly disease, while another woman shares how she was able to avoid passing on an illness to her newborn child because of a vaccine.
The TV spot then shows images of doctors and nurses administering vaccines, as well as people lining up to get their shots. The ad makes it clear that getting vaccinated is not only important for individuals but for the greater good of society as a whole.
The commercial ends with a message encouraging viewers to get vaccinated and reminding them that Walgreens offers a variety of vaccines for adults and children. The overall message of the TV spot is that vaccines save lives and protect communities, and that everyone has a 'Shot at Life.'
Walgreens TV commercial - Shot at Life produced for
Walgreens
was first shown on television on September 1, 2014.
Frequently Asked Questions about walgreens tv spot, 'shot at life'
The Get a Shot. Give a Shot® program will help provide 100 million lifesaving vaccines to children in need around the world by 2024.
The PCV20 dose should be given at least 5 years after the last pneumococcal vaccine. Their vaccines are then complete. The second dose of PPSV23 should be given at least 8 weeks after PCV13 and 5 years after PPSV23. No additional pneumococcal vaccines are recommended until at least age 65 years.
The RSV vaccines work by introducing an inactivated RSV protein into the body, where it fuses to host cells and stimulates the immune system to recognize the actual RSV virus if/when it encounters it and help prevent severe disease.
The pneumococcal vaccine helps protect against serious illnesses like pneumonia and meningitis. It's recommended for people at higher risk of these illnesses, such as babies and adults aged 65 and over.
Vaxneuvance®: Vaccine providers give this vaccine to children at 2, 4, 6, and 12 through 15 months old and to older children who need it. Vaccine providers also give this vaccine to adults 65 years or older and other adults who need it.
One issue was that a few people in the trials developed Guillain-Barré syndrome in the days following the shot. Guillain-Barré is a rare disorder that causes muscle weakness and sometimes paralysis.
You should not get the RSV vaccine Arexvy if you've ever had a severe allergic reaction to any component of Arexvy.
People who need a pneumonia vaccine should get both shots: first, the PCV13 shot and then the PPSV23 shot a year or more later. For most people, one of each shot should be enough to protect them for their entire lives. Sometimes, you may need a booster shot. Ask your doctor whether you should get one.
Pneumococcal Vaccine Side Effects
Vaccines, like any medicine, can have side effects. The most common side effects from pneumococcal vaccines are mild and last for 1 or 2 days. Very rarely, severe (anaphylactic) allergic reactions may occur after vaccination.
If you get pneumococcal vaccines for the first time at 65 or older, you will need two shots, one year apart. If you've had only one pneumococcal vaccine in your lifetime, you may now need an additional shot. If you had the pneumococcal vaccine before you were 65, you may now need one or two additional shots.
July 22 (Reuters) - Denmark-based Bavarian Nordic (BAVA.CO) said on Saturday it was ending its respiratory syncytial virus (RSV) vaccine programme as its Phase 3 clinical trial did not meet all the primary goals of preventing lower respiratory tract disease.
You should not get the RSV vaccine Arexvy if you've ever had a severe allergic reaction to any component of Arexvy.